420 related articles for article (PubMed ID: 23861265)
1. Evaluation of a gelatin matrix as a topical hemostatic agent for hepatic bleeding in the dog.
Polidoro DP; Kass PH
J Am Anim Hosp Assoc; 2013; 49(5):308-17. PubMed ID: 23861265
[TBL] [Abstract][Full Text] [Related]
2. Topical hemostatic agents for bone bleeding in humans. A quantitative comparison of gelatin paste, gelatin sponge plus bovine thrombin, and microfibrillar collagen.
Harris WH; Crothers OD; Moyen BJ; Bourne RB
J Bone Joint Surg Am; 1978 Jun; 60(4):454-6. PubMed ID: 566756
[TBL] [Abstract][Full Text] [Related]
3. Topical hemostatic agents to reduce bleeding from cancellous bone. A comparison of microcrystalline collagen, thrombin, and thrombin-soaked gelatin foam.
Cobden RH; Thrasher EL; Harris WH
J Bone Joint Surg Am; 1976 Jan; 58(1):70-3. PubMed ID: 1249114
[TBL] [Abstract][Full Text] [Related]
4. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
5. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding.
MacDonald MH; Zhang G; Tasse L; Wang D; De Leon H; Kocharian R
J Mater Sci Mater Med; 2021 Sep; 32(10):127. PubMed ID: 34591193
[TBL] [Abstract][Full Text] [Related]
7. An Efficacy Comparison of Two Hemostatic Agents in a Porcine Liver Bleeding Model: Gelatin/Thrombin Flowable Matrix versus Collagen/Thrombin Powder.
Slezak P; Keibl C; Redl H; Labahn D; Gulle H
J Invest Surg; 2020 Oct; 33(9):828-838. PubMed ID: 30907197
[No Abstract] [Full Text] [Related]
8. Topical haemostatics in renal trauma--an evaluation of four different substances in an experimental setting.
Björses K; Holst J
J Trauma; 2009 Mar; 66(3):602-11. PubMed ID: 19276727
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety, and physicochemical properties of a flowable hemostatic agent made from absorbable gelatin sponge via vacuum pressure steam sterilization.
Zhou Y; Ma X; Li Z; Wang B
J Biomater Appl; 2021 Feb; 35(7):776-789. PubMed ID: 32838612
[TBL] [Abstract][Full Text] [Related]
10. Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery.
Fiss I; Danne M; Stendel R
Neurol Med Chir (Tokyo); 2007 Oct; 47(10):462-7. PubMed ID: 17965563
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Efficacy Evaluation of Recombinant Topical Thrombin (RECOTHROM
Slezak P; Keibl C; Labahn D; Schmidbauer A; Genyk Y; Gulle H
J Invest Surg; 2021 Aug; 34(8):862-868. PubMed ID: 31955627
[TBL] [Abstract][Full Text] [Related]
12. Improved bleeding scores using Gelfoam(®) Powder with incremental concentrations of bovine thrombin in a swine liver lesion model.
Morse DC; Silva E; Bartrom J; Young K; Bass EJ; Potter D; Bieber T
J Thromb Thrombolysis; 2016 Oct; 42(3):352-9. PubMed ID: 27334382
[TBL] [Abstract][Full Text] [Related]
13. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
Hutchinson RW; Werrlein S; Johns DB; Zhang G; Clymer JW; Kocharian R
Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
[TBL] [Abstract][Full Text] [Related]
14. A novel hemostatic sealant composed of gelatin, transglutaminase and thrombin effectively controls liver trauma-induced bleeding in dogs.
Xie X; Tian JK; Lv FQ; Wu R; Tang WB; Luo YK; Huang YQ; Tang J
Acta Pharmacol Sin; 2013 Jul; 34(7):983-8. PubMed ID: 23645012
[TBL] [Abstract][Full Text] [Related]
15. Two-layer sheet of gelatin: A new topical hemostatic agent.
Takagi T; Tsujimoto H; Torii H; Ozamoto Y; Hagiwara A
Asian J Surg; 2018 Mar; 41(2):124-130. PubMed ID: 27816406
[TBL] [Abstract][Full Text] [Related]
16. Application of a Thrombin-Gelatin Matrix in the Management of Intractable Hemorrhage During Stereotactic Biopsy.
de Quintana-Schmidt C; Leidinger A; Teixidó JM; Bertrán GC
World Neurosurg; 2019 Jan; 121():180-185. PubMed ID: 30326309
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study.
Gazzeri R; Galarza M; Neroni M; Alfieri A; Giordano M
Acta Neurochir (Wien); 2011 Jan; 153(1):148-54; discussion 155. PubMed ID: 20703888
[TBL] [Abstract][Full Text] [Related]
18. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures.
Gazzeri R; Galarza M; Alfier A
Surg Technol Int; 2012 Dec; 22():49-54. PubMed ID: 22915500
[TBL] [Abstract][Full Text] [Related]
19. The FINISH-3 trial: a phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis.
Bochicchio GV; Gupta N; Porte RJ; Renkens KL; Pattyn P; Topal B; Troisi RI; Muir W; Chetter I; Gillen DL; Zuckerman LA; Frohna PA
J Am Coll Surg; 2015 Jan; 220(1):70-81. PubMed ID: 25458801
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of thrombin loaded TEMPO-oxidized cellulose nanofiber-gelatin sponges and their hemostatic behavior in rat liver hemorrhage model.
Ibne Mahbub MS; Sultana T; Gwon JG; Lee BT
J Biomater Sci Polym Ed; 2022 Mar; 33(4):499-516. PubMed ID: 34644247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
